Symbol="PRQR"
AssetType="Common Stock"
Name="ProQR Therapeutics BV"
Description="ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands."
CIK="1612940"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="ZERNIKEDREEF 9, LEIDEN, NL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="133414000"
EBITDA="-56298000"
PERatio="None"
PEGRatio="0"
BookValue="0.729"
DividendPerShare="0"
DividendYield="0"
EPS="-0.94"
RevenuePerShareTTM="0.058"
ProfitMargin="0"
OperatingMarginTTM="-13.37"
ReturnOnAssetsTTM="-0.205"
ReturnOnEquityTTM="-0.75"
RevenueTTM="4268000"
GrossProfitTTM="4802000"
DilutedEPSTTM="-0.94"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.434"
AnalystTargetPrice="4.01"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="29.24"
PriceToBookRatio="1.702"
EVToRevenue="9.84"
EVToEBITDA="-0.502"
Beta="0.0133"
num_52WeekHigh="3.85"
num_52WeekLow="0.722"
num_50DayMovingAverage="1.823"
num_200DayMovingAverage="2.043"
SharesOutstanding="80936000"
DividendDate="None"
ExDividendDate="None"
symbol="PRQR"
open="1.72"
high="1.73"
low="1.67"
price="1.68"
volume="365311.00"
latest_trading_day="2023-07-13"
previous_close="1.71"
change="-0.03"
change_percent="-1.7544%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="73"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="27"
Volume_recent_avg="677294"
Change_recent_avg="-0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.46"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="27"
Aroon_momentum_negative="73"
image_negative_thumbnail_id_1="518"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0087.jpeg"
image_negative_thumbnail_id_2="130"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_neutral_thumbnail_id_1="556"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="986"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0148.jpeg"
image_positive_thumbnail_id_2="622"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0086.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
